Pro-inflammatory markers such as IL-6, IL-8, CRP and TNF-α have shown to be elevated beyond normal levels in both breast and prostate cancer patients experiencing CRF [23,24]. The gene discussed is CXCL8; the disease is prostate carcinoma.